Document Detail


Validation of a postfixation tissue storage and transport medium to preserve histopathology and molecular pathology analyses (total and phosphoactivated proteins, and FISH).
MedLine Citation:
PMID:  22338055     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tumor biomarker studies are integral to oncology clinical trials but may yield artifactual results owing to variation in sample procurement and processing. Ethanol, 70% vol/vol, was validated as a sample transport medium using markers of the PI3K/Akt/mTOR pathway. BT474 tumor xenografts were excised and slices were immediately placed into formaldehyde and fixed for 24 hours. Fixed tissue slices were immediately processed into paraffin or transferred to 70% vol/vol ethanol and stored at room temperature for 1, 2, and 4 weeks before further processing. Freshly cut tissue sections were evaluated for pAKT(S473), HER2, pHER-2(Y1248), pS6(S235/236), and pS6(S240/244), Ki-67, and HER2 by fluorescence in situ hybridization and stained with H&E and Masson trichrome. No significant changes were observed when comparing samples stored in 70% ethanol for up to 4 weeks with immediately processed tissue. Ethanol, 70% vol/vol, provides a safe storage medium for formaldehyde-fixed tumor tissue, facilitating sample transport during multicenter clinical trials.
Authors:
Michael M Stumm; Maja R Walker; Caroline Stork; Noelle Hanoteau; Urs Wagner; Terence M O'Reilly
Related Documents :
10702645 - Differentiation mechanisms and malignancy.
8393325 - Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a lar...
19965635 - Suppression of b-cell lymphomagenesis by the bh3-only proteins bmf and bad.
11115495 - Oncogenes induce and activate endogenous p73 protein.
23529305 - The value of pax8 and wt1 molecules in ovarian cancer diagnosis.
21892285 - Therapeutic anti-tumor vaccines: from tumor inhibition to enhancement.
Publication Detail:
Type:  Journal Article; Validation Studies    
Journal Detail:
Title:  American journal of clinical pathology     Volume:  137     ISSN:  1943-7722     ISO Abbreviation:  Am. J. Clin. Pathol.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-02-16     Completed Date:  2012-04-03     Revised Date:  2012-10-12    
Medline Journal Info:
Nlm Unique ID:  0370470     Medline TA:  Am J Clin Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  429-36     Citation Subset:  AIM; IM    
Affiliation:
Oncology Research, Novartis Institutes of Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Line, Tumor
DNA / analysis,  chemistry
Ethanol / chemistry
Female
Fixatives / chemistry
Formaldehyde / chemistry
Histocytological Preparation Techniques / methods*
Humans
In Situ Hybridization, Fluorescence*
Mammary Neoplasms, Experimental / genetics,  metabolism,  pathology
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Proteins / metabolism
Pathology, Molecular / methods*
Phosphatidylinositol 3-Kinases / metabolism
Phosphorylation
Proto-Oncogene Proteins c-akt / metabolism
Receptor, erbB-2 / genetics,  metabolism
Specimen Handling / methods*
Time Factors
Tumor Markers, Biological / metabolism
Chemical
Reg. No./Substance:
0/Fixatives; 0/Neoplasm Proteins; 0/Tumor Markers, Biological; 50-00-0/Formaldehyde; 64-17-5/Ethanol; 9007-49-2/DNA; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 2.7.10.1/ERBB2 protein, human; EC 2.7.10.1/Receptor, erbB-2; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CD138 (Syndecan-1) Expression in Bone-Forming Tumors.
Next Document:  Correlation of Histopathologic/Cytologic Follow-up Findings With Vaginal ASC-US and ASC-H Papanicola...